Molecular Dynamics Modeling Simulation Platform software

The Food and Drug Administration's Office of Product Quality and Research is seeking to procure a molecular dynamics modeling simulation platform software through this Request for Quote. The FDA requires a high-performance software license with advanced capabilities for simulating biological interactions, protein-excipient interactions, and molecular dynamics specifically tailored for pharmaceutical research and regulatory review purposes. The software must include machine learning-based molecular property prediction capabilities, support for simulating complex molecular systems, and functionality for protein structure analysis and drug formulation studies. The evaluation will be conducted using a Lowest Price Technically Acceptable (LPTA) method, with the government intending to award without clarification or discussions. Responses are due by August 22, 2025, at 1:00 PM EST, with only eight days provided for vendors to prepare their submissions.

This solicitation does not utilize any small business set-aside designations and is open to all qualified vendors. No incumbent contractors or potential award values are specified in the available documentation. The contract structure is a 12-month firm-fixed-price purchase order for the software licensing arrangement. The software must be compatible with specific hardware specifications including a Precision 7920 Tower with 128GB memory, dual Nvidia RTX A5000 GPUs, and Ubuntu operating system. Performance will take place in Silver Spring, Maryland, presumably at FDA facilities where the specialized hardware configuration is located. The technical requirements indicate this is a sophisticated scientific computing application requiring substantial computational resources for molecular simulation work.